pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
LACTIN-V
LACTIN-V
Bacterial Vaginosis
Osel Inc
LACTULOSE SOLUTION
LACTULOSE SOLUTION (LACTULOSE SOLUTION USP, 10 G/15 ML)
no indication
BAJAJ
Preclinical
LADR-7
Head And Neck Squamous Cell Carcinoma (HNSC)
LadRx Corp
Phase 1
← prev
page 102 of 231
next →
131
Pain
89
Neurology
1
LAE-102
Obesity
Laekna Inc
LAMIVUDINE AND ZIDOVUDINE
LAMIVUDINE AND ZIDOVUDINE
no indication
MACLEODS PHARMS LTD
LARIN 1.5/30
LARIN 1.5/30 (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL)
no indication
NOVAST LABS
Phase 2
LASN-01
Graves' Ophthalmopathy
Lassen Therapeutics 1 Inc
Phase 2
LAT-010
Breast Cancer
Latticon Antibody Therapeutics Inc
Phase 2
LB-100
Myelodysplastic Syndrome (Preleukemia)
$LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Phase 3
LB-102
Schizophrenia
$LBRX
LB PHARMACEUTICALS INC
Preclinical
LB-104
Depression
$LBRX
LB PHARMACEUTICALS INC
Phase 1
LB-1908
Adenocarcinoma Of The Gastroesophageal Junction
$LEGN
Legend Biotech Corp
Phase 2
LB-2102
Neuroendocrine Carcinoma
$NVS
NOVARTIS AG
Preclinical
LB-P4
Alzheimer's Disease
LISCure Biosciences Inc
Phase 2
LB-P8
Primary Sclerosing Cholangitis
LISCure Biosciences Inc
Preclinical
LBL-043
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Nanjing Leads Biolabs Co Ltd
Preclinical
LBL-049
Cancer Anorexia-Cachexia Syndrome
Nanjing Leads Biolabs Co Ltd
Preclinical
LBL-051
Lupus Nephritis
Nanjing Leads Biolabs Co Ltd
Preclinical
LBL-061
Head And Neck Squamous Cell Carcinoma (HNSC)
Nanjing Leads Biolabs Co Ltd
Preclinical
LBP-02
Ulcerative Colitis
Shenzhen UnknownBio Biotechnology Co Ltd
Phase 2
LBPEC-01
Escherichia coli Infections
Locus Biosciences Inc
Phase 1
LBX-200
Inherited Metabolic Disorders
Liberyx Therapeutics Ltd
Preclinical
LCB-39
Breast Cancer
LigaChem Biosciences Inc
Phase 2
LCB-71
Diffuse Large B-Cell Lymphoma
CStone Pharmaceuticals Co Ltd
Preclinical
LCTG-001
Common Variable Immunodeficiency (CVID)
Lactiga Inc
LEADER 12 HOUR SINUS NASAL DECONGESTANT
LEADER 12 HOUR SINUS NASAL DECONGESTANT (PSEUDOEPHEDRINE HCL)
no indication
L PERRIGO CO
LEDIPASVIR AND SOFOSBUVIR
LEDIPASVIR AND SOFOSBUVIR
no indication
GILEAD SCIENCES INC
LEVALBUTEROL
LEVALBUTEROL
no indication
LUOXIN AUROVITAS
LEVONORGETSREL AND ETHINYL ESTRADIOL
LEVONORGETSREL AND ETHINYL ESTRADIOL
no indication
HETERO LABS
Phase 2
LG-631
Glioblastoma Multiforme (GBM)
Lentigen Technology Inc
